Imatinib intermediates 106261-49-8 | 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride Professional Manufacturer

 

product Name 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride hemihydrate
Synonyms 4-[(4-methyl-1-piperazinyl)methyl]benzoic acid dihydrochloride hemihydrate; 4-[(4-Methyl-1-piperaziny)methyl]benzoic acid dihydrochloride hemihydrate; 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride; N-(2-methyl-5-nitrophenyl)-4-pyridin-3-ylpyrimidin-2-amine dihydrochloride hemihydrate; 4-[(4-Methyl-1-Piperazinyl)methyl]benzoic acid dihydrochloride; 4-[1-(4-methyl piperazinyl) methyl]-benzoic acid dihydrochloride; 4-[(4-methyl piperazine1-yl) methyl] benzoic acid dihydrochloride; Benzoic acid,4-[(4-methyl-1-piperazinyl)methyl]-, hydrochloride; 4-(4-Methyl-1-piperazinyl)methyl]benzoyl acid dihydrochloride; 4-[(4-Methylpiperazin-1-yl)methyl]-benzoic acid dihydrochloride; 4-((4-methylpiperazin-1-yl)methyl)benzoic acid dihydrogen chloride; 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloridehemihydrate; 4-[(4-methyl-1-piperazinyl)methyl]benzoic acid 2HCl; Benzoic acid,4-[(4-methyl-1-piperazinyl)methyl]-,hydrochloride; 4-(4-Methylpiperazinomethyl)benzoic Acid Dihydrochloride
Molecular Formula C16H13N5O2
Molecular Weight 307.3067
InChI InChI=1/C16H13N5O2/c1-11-4-5-13(21(22)23)9-15(11)20-16-18-8-6-14(19-16)12-3-2-7-17-10-12/h2-10H,1H3,(H,18,19,20)
CAS Registry Number 106261-49-8
Molecular Structure 106261-49-8 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride hemihydrate

Density 1.345g/cm3
Melting point 305-307℃
Boiling point 546.609°C at 760 mmHg
Refractive index 1.675
Flash point 284.379°C
Vapour Pressur 0mmHg at 25°C
Chemical Properties White Solid
Uses 4-(4-Methylpiperazinomethyl)benzoic Acid, Dihydrochloride (cas# 106261-49-8) is a compound useful in organic synthesis.
 

Reviews

There are no reviews yet.

Be the first to review “Imatinib intermediates 106261-49-8 | 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride Professional Manufacturer”

Your email address will not be published. Required fields are marked *